Self-organized stem cell-derived human lung buds with proximo-distal patterning and novel targets of SARS-CoV-2.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
06 Jan 2021
06 Jan 2021
Historique:
pubmed:
15
1
2021
medline:
15
1
2021
entrez:
14
1
2021
Statut:
epublish
Résumé
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the global COVID-19 pandemic and the lack of therapeutics hinders pandemic control
Identifiants
pubmed: 33442697
doi: 10.1101/2021.01.06.425622
pmc: PMC7805464
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NIAID NIH HHS
ID : R01 AI091707
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI111825
Pays : United States
Déclaration de conflit d'intérêts
Competing interests A.H.B. is a co-founder of 2 startup companies: Rumi Scientific Inc. and OvaNova Laboratories, LLC and serves on their scientific advisory boards. C.M.R. is a founder of Apath LLC, a Scientific Advisory Board member of Imvaq Therapeutics, Vir Biotechnology, and Arbutus Biopharma, and an advisor for Regulus Therapeutics and Pfizer. All other authors declare no competing interests.